H.I.G. Capital Acquires Celerion
November 3, 2022
H.I.G. Capital (through an affiliate) completed the acquisition of Celerion Holdings, Inc., a global clinical research organization headquartered in Lincoln, Nebraska. Celerion provides end-to-end early-stage clinical trial and bioanalytical services to pharmaceutical and biotechnology clients; H.I.G. said the investment expands its pharma services platform and supports Celerion's growth plans.
- Buyers
- H.I.G. Capital
- Targets
- Celerion Holdings, Inc.
- Industry
- Healthcare Services
- Location
- Nebraska, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.